Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 50:933-939, doi:10.1016/j.jacc.2007.04.082 (Published online 20 August 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.04.082v1
50/10/933    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubo, T.
Right arrow Articles by Akasaka, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kubo, T.
Right arrow Articles by Akasaka, T.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: ATHEROMA MORPHOLOGY

Assessment of Culprit Lesion Morphology in Acute Myocardial Infarction

Ability of Optical Coherence Tomography Compared With Intravascular Ultrasound and Coronary Angioscopy

Takashi Kubo, MD, PhD*, Toshio Imanishi, MD, PhD, Shigeho Takarada, MD, PhD, Akio Kuroi, MD, Satoshi Ueno, MD, Takashi Yamano, MD, Takashi Tanimoto, MD, Yoshiki Matsuo, MD, PhD, Takashi Masho, MD, Hironori Kitabata, MD, Kazushi Tsuda, MD, PhD, Yoshiaki Tomobuchi, MD, PhD and Takashi Akasaka, MD, PhD

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan

Manuscript received December 20, 2006; revised manuscript received April 12, 2007, accepted April 17, 2007.

* Reprint requests and correspondence: Dr. Takashi Akasaka, Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan. (Email: akasat{at}wakayama-med.ac.jp).


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 Conclusions
 References
 
Objectives: The aim of the present study was to evaluate the ability of optical coherence tomography (OCT) for assessment of the culprit lesion morphology in acute myocardial infarction (AMI) in comparison with intravascular ultrasound (IVUS) and coronary angioscopy (CAS).

Background: Optical coherence tomography is a new intravascular imaging method with a high resolution of approximately 10 µm. This may allow us to assess the vulnerable plaques in detail in vivo.

Methods: We enrolled 30 patients with AMI, and analyzed the culprit lesion by OCT, CAS, and IVUS.

Results: The average duration from the onset of symptom to OCT imaging was 3.8 ± 1.0 h. The incidence of plaque rupture observed by OCT was 73%, and it was significantly higher than that by CAS (47%, p = 0.035) and IVUS (40%, p = 0.009). Furthermore, OCT (23%) was superior to CAS (3%, p = 0.022) and IVUS (0%, p = 0.005) in the detection of fibrous cap erosion. The intracoronary thrombus was observed in all cases by OCT and CAS, but it was identified in 33% by IVUS (vs. OCT, p < 0.001). Only OCT could estimate the fibrous cap thickness, and it was 49 ± 21 µm. The incidence of thin cap fibroatheroma (TCFA) was 83% in this population by OCT.

Conclusions: Optical coherence tomography is a feasible imaging modality in patients with AMI and allows us to identify not only plaque rupture, but also fibrous cap erosion, intracoronary thrombus, and TCFA in vivo more frequently compared with conventional imaging techniques.

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  CAS = coronary angioscopy
  IVUS = intravascular ultrasound
  OCT = optical coherence tomography
  TCFA = thin cap fibroatheroma
  TIMI = Thrombosis In Myocardial Infarction


It is generally accepted that culprit lesions of acute myocardial infarction (AMI) typically have severe stenosis secondary to superimposed thrombus at the time of the event but not necessarily severe stenosis before the event (1,2). Pathologically, AMI is provoked by sudden rupture or ulcer formation of vulnerable plaque followed by subsequent thrombosis (3,4). The pathological characteristics of vulnerable plaques include a thin fibrous cap with macrophage infiltration and a large lipid pool (4). These findings were based on the postmortem histological examination, and the imaging of the vulnerable plaque characteristics was limited in vivo. Coronary angiography provided the first in vivo imaging of the coronary arteries. Pathohistological correlations of angiographic lesion morphologies have demonstrated that lesions with irregular borders and intraluminal lucencies corresponded to complex plaque with thrombosis (5). Intravascular ultrasound (IVUS) has become standard invasive method for diagnosing coronary artery disease. Recent reports have suggested that the presence of the positive vascular remodeling and hypoechoic regions corresponding to lipid-rich tissue in coronary plaques on IVUS images were related to acute coronary events (6). Coronary angioscopic (CAS) investigations have indicated that AMI occurs more frequently in patients with glistening yellow plaques than in those with white plaques (7). Moreover, thrombus arising from the ruptured identical plaques was confirmed in the culprit lesion of the AMI by CAS.

Intravascular optical coherence tomography (OCT) has recently been proposed as a high-resolution imaging method for plaque characterization (8–12). Optical coherence tomography is an optical analogue of IVUS, and its resolution is approximately 10 to 20 µm, which is about 10 times higher than IVUS. The histology-controlled studies have shown that the OCT can resolve microstructure of atherosclerotic plaque such as thin fibrous cap, lipid core, and intracoronary thrombus, which are thought to be responsible for plaque vulnerability (13,14). Therefore, we hypothesized that this new technique might allow us to observe vulnerable plaques in detail compared with conventional imaging modalities. The aims of this study were: 1) to assess the ability of OCT for visualization of vulnerable plaque features in comparison with IVUS and CAS; and 2) to evaluate the characteristics of culprit lesions in living patients with AMI by OCT.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 Conclusions
 References
 
Study population.   The AMI patients, who had continuous chest pain lasting >30 min, arrival at our hospital within 6 h from the onset of the symptom, ST-segment elevation ≥0.1 mV in 2 or more contiguous leads on 12-lead electrocardiogram (ECG), and an identifiable culprit lesion in a native coronary artery by coronary angiography, were enrolled in this study. Exclusion criteria were presence of left bundle-branch block or pacemaker rhythm, a culprit lesion in the left main coronary artery, history of myocardial infarction, cardiogenic shock, unsuccessful reperfusion of Thrombolysis In Myocardial Infarction (TIMI) flow grade 3 by initial aspiration thrombectomy before the imaging, and the failure in advancing the CAS, IVUS, or OCT catheter to the culprit lesion. After observation by various imaging modalities, percutaneous coronary intervention was performed. Demographic and clinical data were prospectively collected. This protocol was approved by the Wakayama Medical University Ethics Committee, and all patients provided informed consent before participation.

Image acquisition.   Oral aspirin (162 mg) and intravenous heparin (100 U/kg) were administered before coronary intervention. Thrombolysis was not performed for any patient. Cardiac catheterization was performed by the conventional femoral approach, using a 7-F sheath and catheters. The culprit lesion was identified on the basis of the findings by a coronary angiogram as well as an ECG and transthoracic echocardiogram. In patients with TIMI flow grade ≤II, aspiration thrombectomy was performed by an aspiration catheter (Export catheter, Medtronic Japan, Tokyo, Japan) before intracoronary imaging, but predilation by balloon catheter was not allowed. After reperfusion with TIMI flow grade 3, the culprit lesion was observed by IVUS, CAS, and then OCT as described previously (8,13,15). First, IVUS (Atlantis SR Pro 2.5F, 40-MHz; Boston Scientific, Natick, Massachusetts) examination was performed with an automatic pullback device at a rate of 0.5 mm/s. Second, the observation by CAS (Vecmova, Clinical Supply Co., Gifu, Japan) was made while blood was cleared away from view by the injection of 5 to 10 ml saline. Lastly, a 0.016-inch OCT catheter (ImageWire, LightLab Imaging, Westford, Massachusetts) was advanced to the distal end of the culprit lesion through a 3-F occlusion balloon catheter. In order to remove the blood from the field of view, occlusion balloon was inflated to 0.6 atm at proximal site of the culprit lesion, and lactate Ringer's solution was infused into the coronary artery from the distal tip of the occlusion balloon catheter at 0.5 ml/s. The entire length of the culprit lesion was imaged with an automatic pullback device moving at 1 mm/s, and the OCT image clearly visualized the culprit lesion.

Image analysis.   All images were recorded digitally and were analyzed by 2 independent investigators who were blinded to the clinical presentation. When there was discordance between the observers, a consensus reading was obtained. The corresponding images of IVUS, CAS, and OCT were identified by the distances from 2 landmarks, such as side branches. The presence of fibrous cap disruption, fibrous cap erosion, or an intracoronary thrombus was also noted. Fibrous cap disruption was identified by a presence of fibrous cap discontinuity and a cavity formation of the plaque (Fig. 1). Fibrous cap erosion was characterized by loss of the endothelial lining with lacerations of the superficial intimal layers and without "trans-cap" ruptures (Fig. 2). Intracoronary thrombus was identified by the mass images protruding into the vessel lumen from the surface of the vessel wall (Fig. 3). Furthermore, OCT images were analyzed using validated criteria for plaque characterization, and fibrous cap thickness was determined as reported previously (13,14). Briefly, fibrous cap thickness in nonruptured plaque was defined as the minimum distance from the coronary artery lumen to inner border of lipid pool, which was characterized by signal-poor region in OCT image. In the ruptured plaque, residual fibrous cap was identified as a flap between the lumen of coronary artery and the cavity of plaque, and its thickness was measured at the thinnest part (Fig. 4). Cap thicknesses for each image were measured at 3 different times, and the average value was computed. Lipid was semiquantified as the number of involved quadrants on the cross-sectional OCT image. When lipid was present in ≥2 quadrants in any of the images within a plaque, it was considered a lipid-rich plaque. For each patient, the cross-sectional image with the highest number of lipid quadrants was used for analysis. Thin cap fibroatheroma (TCFA) was defined as a plaque with lipid content in ≥2 quadrants and the thinnest part of a fibrous cap measuring ≤65 µm. Interobserver and intraobserver variabilities were assessed by the evaluation of all images by 2 independent readers and by the same reader at 2 separate time points, respectively.


Figure 1
View larger version (46K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Images of Typical Fibrous Cap Disruption

Fibrous cap disruption in corresponding images of optical coherence tomography (A), coronary angioscopy (B), and intravascular ultrasound (C). (A) Lipid-rich plaque (L) with localized disruption of a fibrous cap with a flap protruding into lumen (arrow). (B) Yellow lesion with fibrous cap disruption (arrows) and large ulceration (U). (C) Eccentric plaque ruptured at the shoulder (arrow).

 

Figure 2
View larger version (48K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Images of Typical Fibrous Cap Erosion

Fibrous cap erosion in corresponding images of optical coherence tomography (A), coronary angioscopy (B), and intravascular ultrasound (C). (A) Erosion located on the surface of a plaque (arrows) with intraluminal thrombus (T). (B) Rough surface erosion without disrupted fibrous cap protruding into lumen (arrows). (C) No identification of fibrous cap erosion.

 

Figure 3
View larger version (41K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Images of Typical Intraluminal Thrombi

Intraluminal thrombi in corresponding images of optical coherence tomography (A), coronary angioscopy (B), and intravascular ultrasound (C). (A) Thrombus with optical coherence tomography signal attenuation (T). (B) Large white thrombus (WT) and small red thrombus (RT) adhering to a rough surface of yellow plaque. (C) Thrombus (arrows) identified the mass images protruding into the vessel lumen from the surface of the vessel wall.

 

Figure 4
View larger version (167K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Measurement of Fibrous Cap Thickness

Measurement of fibrous cap thickness in ruptured plaque using optical coherence tomography. Residual fibrous cap was identified as a flap between the lumen of the coronary artery and the cavity of plaque, and its thickness was measured at the thinnest part (arrows). Scale bar = 1 mm.

 
Statistical analysis.   Data are expressed as mean ± SD or median with range. The incidences of fibrous cap disruption, fibrous cap erosion, or intracoronary thrombus were compared between imaging modalities by use of chi-square test or Fisher exact test. To control for multiple comparisons, pairwise tests of incidence were performed, if the contingency table for all 3 imaging techniques was significant. Intraobserver and interobserver variabilities were measured by {kappa} test of concordance. All analysis required a value of p < 0.05 for statistical significance.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 Conclusions
 References
 
Baseline characteristics.   A total of 41 patients with AMI were consecutively enrolled. Eleven patients were excused according to exclusion criteria, and 30 patients were presented in this study. The baseline characteristics are demonstrated in Table 1. The mean age in these patients was 69 years old. In coronary risk factors, the prevalence of diabetes mellitus and hypercholesterolemia was 30% and 53%, respectively. There are no patients with chronic renal insufficiency or hemodialysis. The culprit lesions were easily identified by coronary angiography. Averaged percent diameter stenosis of culprit lesions before intracoronary imaging was 88 ± 26%, and TIMI flow grade 0 was most frequent. In 6 patients with TIMI flow grade 3, aspiration thrombectomy was not required. The average duration from the onset of symptom to OCT imaging was 3.8 ± 1.0 h. In all cases, the corresponding OCT, CAS, and IVUS images were obtained by only 1 pullback procedure. Because reference vessel diameter was <4 mm in this population, clear OCT images were provided in spite of limited penetration of OCT signal. The total coronary occlusion time necessary for CAS and OCT was 18 ± 7 s and 37 ± 4 s, respectively. The averaged procedure time required to complete imaging by 3 methods, including imaging catheters exchanges, was <13 min. Although ST-segment re-elevation on ECG was observed in all patients during imaging procedures, it disappeared soon after the procedures by releasing the coronary occlusion. The major complications and adverse events did not occur in the present study.


View this table:
[in this window]
[in a new window]

 
Table 1 Baseline Characteristics of 30 Patients With AMI
 
OCT, CAS, and IVUS findings for corresponding images.   The OCT, CAS, and IVUS findings for corresponding images are summarized in Table 2. The incidence of fibrous cap disruption was significantly different among the imaging techniques (73%, 47%, and 40% in OCT, CAS, and IVUS, respectively; p = 0.021). Difference in the incidence of fibrous cap disruption was significant between OCT and CAS (p = 0.035) or OCT and IVUS (p = 0.009), but not between CAS and IVUS (p = 0.602). In the detection of fibrous cap erosion, there was a significant difference among the imaging techniques (23%, 3%, and 0% in OCT, CAS, and IVUS, respectively; p = 0.003). Difference in the incidence of erosion was significant between OCT and CAS (p = 0.026) or between OCT and IVUS (p = 0.005), but not between CAS and IVUS (p = 0.500). The intracoronary thrombus was observed in all cases by OCT and CAS, but it was identified only in 33% by IVUS (p < 0.001). The incidence of thrombus was significantly different between OCT and IVUS (p < 0.001) or between CAS and IVUS (p < 0.001), but not different between OCT and CAS (p = 1.000). In addition, only OCT could estimate the fibrous cap thickness, and it was 49 ± 21 µm (Table 3). The lipid-rich plaque was observed in 93% and the frequency of TCFA was 83% of patients with AMI in the OCT findings.


View this table:
[in this window]
[in a new window]

 
Table 2 OCT, CAS, and IVUS Findings for Corresponding Images
 

View this table:
[in this window]
[in a new window]

 
Table 3 OCT Findings of the Culprit Lesion in 30 Patients With AMI
 
Intraobserver and interobserver variability.   Intraobserver variability yielded acceptable concordance for fibrous cap disruption ({kappa} = 0.83), erosion ({kappa} = 0.77), intracoronary thrombus ({kappa} = 0.73), and TCFA ({kappa} = 0.79). Interobserver variability showed slightly lower concordance: fibrous cap disruption ({kappa} = 0.77), erosion ({kappa} = 0.67), intracoronary thrombus ({kappa} = 0.61), and TCFA ({kappa} = 0.71).


    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 Conclusions
 References
 
This is the first report assessing the feasibility and safety of OCT, in comparison with CAS and IVUS, for evaluation of vulnerable coronary plaques in patients with AMI. The high resolution of OCT enabled visualization of the vulnerable plaque characteristics reported by pathohistological study. The fibrous cap disruption, fibrous cap erosion, intracoronary thrombus, and TCFA could be identified more frequently by OCT in comparison with IVUS or CAS. These results indicate that OCT would be an ideal method to identify the vulnerable plaques.

Fibrous cap disruption and erosion.   The OCT allowed us to evaluate the fibrous cap disruption clearly in patients with AMI. Retrospective pathological studies in patients with coronary artery disease who died suddenly showed fibrous cap disruption in 70% of patients (16,17). One angioscopic evaluation revealed that the prevalence of fibrous cap disruption was 55.5% in patients with AMI (18). Intravascular ultrasound studies have reported varying frequencies of infarct-related fibrous cap disruption (15.8% to 66%) in AMI patients (19,20), and the durations from symptom onset to IVUS imaging were from 10 h to 4 weeks. In the present study using OCT, the time from symptom onset to OCT imaging was 3.8 ± 1.0 h, and the prevalence of fibrous cap disruption was 73%, which was similar to that in postmortem pathohistological examinations and more frequent than those in vivo studies using CAS and IVUS. In addition, OCT was able to evaluate the fibrous cap erosion clearly, and the prevalence of fibrous cap erosion was 23% in patients with AMI in the present study, and this is also thought to be similar frequency compared with that in postmortem pathohistology.

Intracoronary thrombus.   Intracoronary thrombosis might take a critical role in the pathogenesis and the clinical manifestations of AMI (21). But coronary angiography and IVUS could not reliably identify thrombus (22), and CAS was the only available technology to assess it in vivo (23,24). The present study demonstrated that OCT was able to visualize the intracoronary thrombus clearly in all cases as much as CAS. Jang et al. (13) reported that the frequency of thrombus using OCT imaging was only 20% in patients with recent myocardial infarction who had thrombolytic therapy and the average time interval between the onset of symptoms and OCT imaging was 4.6 ± 5.3 days. These OCT investigations revealed that the intraluminal thrombus was an important characteristic of vulnerable plaque, and pharmacologic thrombolytic intervention could have dissolved some thrombi in the AMI patients. Furthermore, the present study would be more reliable in the incidence of the thrombus in the culprit lesion of AMI compared with the previous study because there was a time delay of up to 6 h between the onset and imaging acquisition.

TCFA.   Pathohistologically, TCFAs have a necrotic core with an overlying thin fibrous cap (≤65 µm) infiltrated by macrophages, and they have been defined as precursors to lesions of rupture and erosion (25). Although the identification of TCFA is limited in the conventional imaging modalities in vivo, the high resolution of OCT allows us to identify it clearly (13,26). The present study using OCT demonstrates that the thin fibrous cap and large lipid core must be important characteristics to represent vulnerable plaque in AMI. Optical coherence tomography is a powerful modality for evaluation of vulnerable coronary plaque in vivo, and it may provide a great opportunity to understand the mechanism of AMI onset.

Possibility of OCT for assessing plaque vulnerability..   Optical coherence tomography may be a useful technique for assessing plaque vulnerability. Recent OCT study of culprit lesions demonstrated a higher prevalence of fibrous cap disruption (20% vs. 12%) and TCFA (55% vs. 18%) in patients with acute coronary disease than patients with stable coronary disease (13). The frequency of an intracoronary thrombus was not different in various clinical presentations; however, this unexpected finding may have resulted from a time delay of up to 2 weeks between the acute event and OCT imaging and antithrombotic therapy. These findings represent the observation of presentation-dependent plaque morphology in living human patients and confirm our current knowledge of the relationship between morphology and patient outcome that has been obtained in previous autopsy studies (4).

Arterial positive remodeling and abundant plaque burden are well-described characteristics of vulnerability (4). Several recent IVUS trials have established a relationship between changes in plaque burden and treatment effect with plaque stabilizing medications (e.g., statins) (27–29). Optical coherence tomography is limited in the assessment of plaque burden, because of the limited depth of imaging (2 mm). Intravascular ultrasound is useful for the evaluation of entire vessel wall and plaque in comparison with current OCT system.

An advantage of OCT is the potential to assess macrophage distribution in the context of high-resolution cross-sectional images of plaque morphology. MacNeill et al. (30) demonstrated that increases in both multifocal and focal macrophage densities are highly correlated with symptom severity of coronary atherosclerosis. By providing a means of detecting increases in plaque macrophage content before an acute event, this technique may aid in determining prognosis and guiding preventive therapy.

An important controversy in the discussion about plaque vulnerability is the focal versus systemic nature. It is increasingly obvious that patients at the time of acute presentation have evidence of plaque instability at various sites in the coronary tree. Several imaging modalities including coronary angiography (31), IVUS (32,33), and CAS (34) have demonstrated evidence that plaque vulnerability is a multifocal process. The current OCT system is limited to focal lesion assessment. Simultaneous imaging with IVUS and CAS would allow us to identify additional vulnerable sites, which could then be evaluated by OCT. However, in the present study multifocal assessment was not performed by 3 modalities, because it would take too much time in the highly life-threatened patients. In addition, an inherent limitation of OCT is the need to occlude coronary artery by balloon catheter and to flush lactate Ringer's solution for imaging. Therefore nonculprit vessel occlusion was thought to increase risk in patients with AMI especially at the time of reperfusion. Although still in a relatively early stage of development, frequency domain OCT imaging has already been shown to be a powerful enabling technology, including improvements in interrupting blood flow, higher penetration depth, and faster image acquisition rates (35,36). Next-generation OCT systems may allow screening of long coronary segments and eliminate many of the technical limitations of the present study.

Study limitations.   The coronary thrombectomy was performed for reperfusion before the observations. Although the morphologic feature of the culprit lesion might be affected by this procedure, imaging before treatment would not be appropriate ethically. And the thrombolysis might have been a better treatment before the imaging because it would not influence plaque morphology. Also, IVUS was always done before angioscopy, which was always before OCT, so it is possible that alteration from the IVUS catheter accounted for the findings on angioscopy or OCT. Performing imaging modalities in a random order would have been a better methodological approach. But it is thought that these procedures affect plaque morphology little, because the frequencies of fibrous cap disruption and erosion assessed by OCT were similar to those in postmortem pathohistological examinations.

In addition, the abilities to detect the characteristics of vulnerable plaques were compared between imaging modalities in this study, but none of them serve as "the gold standard." Therefore, based on the pathohistological knowledge, it must be assessed which modality is better for evaluation of vulnerable plaque.


    Conclusions
 Top
 Abstract
 Methods
 Results
 Discussion
 Conclusions
 References
 
Intracoronary OCT is a feasible and safe imaging modality in patients with AMI and allows us to identify plaque ruptures, fibrous cap erosions, TCFA, and intracoronary thrombus in vivo, which has been demonstrated only by histology, more frequently and clearly compared with conventional imaging techniques. The high resolution of OCT provides a greater understanding of the intrinsic morphologic features that determine plaque vulnerability.


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 Conclusions
 References
 
1. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction J Am Coll Cardiol 1988;12:56-62.[Abstract]

2. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-1166.[Abstract/Free Full Text]

3. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi Br Heart J 1983;50:127-134.[Abstract/Free Full Text]

4. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 2000;20:1262-1275.[Free Full Text]

5. Levin DC, Fallon JT. Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations Circulation 1982;66:316-320.[Abstract/Free Full Text]

6. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaques: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary event J Am Coll Cardiol 2000;35:106-111.[Abstract/Free Full Text]

7. Uchida Y, Nakamura F, Tomaru T, et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina Am Heart J 1995;130:195-203.[CrossRef][Web of Science][Medline]

8. Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound J Am Coll Cardiol 2002;39:604-609.[Abstract/Free Full Text]

9. Brezinski ME, Tearney GJ, Bouma BE, et al. Optical coherence tomography for optical biopsyProperties and demonstration of vascular pathology. Circulation 1996;93:1206-1213.[Abstract/Free Full Text]

10. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary intima-media thickness by optical coherence tomography: comparison with intravascular ultrasound Circ J 2005;69:903-907.[CrossRef][Web of Science][Medline]

11. Kume T, Akasaka T, Kawamoto T, et al. Visualization of neointima formation by optical coherence tomography Int Heart J 2005;46:1133-1136.[CrossRef][Web of Science][Medline]

12. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial plaque by optical coherence tomography Am J Cardiol 2006;97:1172-1175.[CrossRef][Web of Science][Medline]

13. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography Circulation 2005;111:1551-1555.[Abstract/Free Full Text]

14. Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography Circulation 2002;106:1640-1645.[Abstract/Free Full Text]

15. Ueda Y, Asakura M, Hirayama A, et al. Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction: serial angioscopic observations J Am Coll Cardiol 1996;27:606-610.[Abstract]

16. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death N Engl J Med 1984;310:1137-1140.[Abstract]

17. Falk E, Shah PK, Fuster V. Coronary plaque disruption Circulation 1995;92:657-671.[Free Full Text]

18. Mizote I, Ueda Y, Ohtani T, et al. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque Circulation 2005;112:1001-1007.[Abstract/Free Full Text]

19. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes Circulation 2001;104:365-372.[Free Full Text]

20. Hong MK, Mintz GS, Lee CW, et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a 3-vessel intravascular ultrasound study in 235 patients Circulation 2004;110:928-933.[Abstract/Free Full Text]

21. Rentrop KP. Thrombi in acute coronary syndromes: revisited and revised Circulation 2000;101:1619-1626.[Free Full Text]

22. Siegel RJ, Ariani M, Fishbein MC, et al. Histopathologic validation of angioscopy and intravascular ultrasound Circulation 1991;84:109-117.[Abstract/Free Full Text]

23. den Heijer P, Foley DP, Escaned J, et al. Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus J Am Coll Cardiol 1994;24:649-654.[Abstract]

24. Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders Lancet 1991;337:809-812.[CrossRef][Web of Science][Medline]

25. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions J Interv Cardiol 2002;15:439-446.[Medline]

26. Kume T, Akasaka T, Kawamoto T, et al. Measurement of the thickness of the fibrous cap by optical coherence tomography Am Heart J 2006;152:755e1–4.[Medline]

27. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 2006;295:1556-1565.[Abstract/Free Full Text]

28. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 2004;291:1071-1080.[Abstract/Free Full Text]

29. Okazaki S, Yokoyama T, Miyauchi K, et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study Circulation 2004;110:1061-1068.[Abstract/Free Full Text]

30. MacNeill BD, Jang IK, Bouma BE, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease J Am Coll Cardiol 2004;44:972-979.[Abstract/Free Full Text]

31. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction N Engl J Med 2000;343:915-922.[Abstract/Free Full Text]

32. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study Circulation 2002;106:804-808.[Abstract/Free Full Text]

33. Schoenhagen P, Stone GW, Nissen SE, et al. Coronary plaque morphology and frequency of ulceration distant from culprit lesions in patients with unstable and stable presentation Arterioscler Thromb Vasc Biol 2003;23:1895-1900.[Abstract/Free Full Text]

34. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study J Am Coll Cardiol 2001;37:1284-1288.[Abstract/Free Full Text]

35. Yun SH, Tearney GJ, Bouma BE, et al. High-speed spectral-domain optical coherence tomography at 1.3 µm wavelength Opt Express 2003;11:3598-3604.[Web of Science][Medline]

36. Yun SH, Tearney GJ, de Boer JF, et al. High-speed optical frequency-domain imaging Opt Express 2003;11:2953-2963.[Web of Science][Medline]


Related Article

From Postmortem Characterization to the In Vivo Detection of Thin-Capped Fibroatheromas: The Missing Link Toward Percutaneous Treatment: What If Diogenes Would Have Found What He Was Looking For?
Patrick W. Serruys, Hector M. Garcia-Garcia, and Evelyn Regar
J. Am. Coll. Cardiol. 2007 50: 950-952. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur Heart JHome page
F. Prati, E. Regar, G. S. Mintz, E. Arbustini, C. Di Mario, I.-K. Jang, T. Akasaka, M. Costa, G. Guagliumi, E. Grube, et al.
Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis
Eur. Heart J., November 4, 2009; (2009) ehp433v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. M. Matter, M. Stuber, and M. Nahrendorf
Imaging of the unstable plaque: how far have we got?
Eur. Heart J., November 1, 2009; 30(21): 2566 - 2574.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon
Intracoronary Optical Coherence Tomography: A Comprehensive Review: Clinical and Research Applications
J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1035 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
A. Maehara, G. S. Mintz, and N. J. Weissman
Advances in Intravascular Imaging
Circ Cardiovasc Interv, October 1, 2009; 2(5): 482 - 490.
[Full Text] [PDF]


Home page
pdiHome page
A. Hubalewska-Dydejczyk, T. Stompor, M. Kalembkiewicz, M. Krzanowski, R. Mikolajczak, A. Sowa-Staszczak, B. Tabor-Ciepiela, U. Karczmarczyk, B. Kusnierz-Cabala, and W. Sulowicz
IDENTIFICATION OF INFLAMED ATHEROSCLEROTIC PLAQUE USING 123I-LABELED INTERLEUKIN-2 SCINTIGRAPHY IN HIGH-RISK PERITONEAL DIALYSIS PATIENTS: A PILOT STUDY
Perit. Dial. Int., September 1, 2009; 29(5): 568 - 574.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H. M Garcia-Garcia, N. Gonzalo, E. Regar, and P. W Serruys
Virtual histology and optical coherence tomography: from research to a broad clinical application
Heart, August 15, 2009; 95(16): 1362 - 1374.
[Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
Min Pan, M.-H. Jiang, M.-F. Wei, Z.-H. Liu, W.-P. Jiang, H.-H. Geng, Z.-C. Cui, D.-L. Zhang, and J.-H. Zhu
Association of Angiotensin-Converting Enzyme Gene 2350G>A Polymorphism With Myocardial Infarction in a Chinese Population
Clinical and Applied Thrombosis/Hemostasis, August 1, 2009; 15(4): 435 - 442.
[Abstract] [PDF]


Home page
Eur Respir JHome page
J. P. Williamson, A. L. James, M. J. Phillips, D. D. Sampson, D. R. Hillman, and P. R. Eastwood
Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques
Eur. Respir. J., July 1, 2009; 34(1): 42 - 55.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
H. Otake, J. Shite, J. Ako, T. Shinke, Y. Tanino, D. Ogasawara, T. Sawada, N. Miyoshi, H. Kato, B.-K. Koo, et al.
Local Determinants of Thrombus Formation Following Sirolimus-Eluting Stent Implantation Assessed by Optical Coherence Tomography
J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 459 - 466.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
G. Guagliumi and M. Costa
From a Foggy Sight to a Clear Vision
J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 467 - 469.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Brar, A. Y.-J. Shen, V. Aharonian, P. Mansukhani, and J. Kim
Reply.
J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2213 - 2213.
[Full Text] [PDF]


Home page
JNMHome page
J. Waldeck, F. Hager, C. Holtke, C. Lanckohr, A. von Wallbrunn, G. Torsello, W. Heindel, G. Theilmeier, M. Schafers, and C. Bremer
Fluorescence Reflectance Imaging of Macrophage-Rich Atherosclerotic Plaques Using an {alpha}v{beta}3 Integrin-Targeted Fluorochrome
J. Nucl. Med., November 1, 2008; 49(11): 1845 - 1851.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.L. Gu, M.L. Fokkema, and F. Zijlstra
The Emerging Role of Thrombus Aspiration in the Management of Acute Myocardial Infarction
Circulation, October 28, 2008; 118(18): 1780 - 1782.
[Full Text] [PDF]


Home page
HeartHome page
O C Raffel, T Akasaka, and I-K Jang
Cardiac optical coherence tomography
Heart, September 1, 2008; 94(9): 1200 - 1210.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Ohayon, G. Finet, A. M. Gharib, D. A. Herzka, P. Tracqui, J. Heroux, G. Rioufol, M. S. Kotys, A. Elagha, and R. I. Pettigrew
Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H717 - H727.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
T. Kubo, T. Imanishi, H. Kitabata, A. Kuroi, S. Ueno, T. Yamano, T. Tanimoto, Y. Matsuo, T. Masho, S. Takarada, et al.
Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris a serial optical coherence tomography study.
J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 475 - 484.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. A. Ambrose
In Search of the "vulnerable plaque": can it be localized and will focal regional therapy ever be an option for cardiac prevention?
J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1539 - 1542.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The year in atherothrombosis.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 944 - 955.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
T. Kubo, T. Imanishi, S. Takarada, A. Kuroi, S. Ueno, T. Yamano, T. Tanimoto, Y. Matsuo, T. Masho, H. Kitabata, et al.
Implication of plaque color classification for assessing plaque vulnerability a coronary angioscopy and optical coherence tomography investigation.
J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 74 - 80.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol., January 29, 2008; 51(4): 490 - 512.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. W. Serruys, H. M. Garcia-Garcia, and E. Regar
From Postmortem Characterization to the In Vivo Detection of Thin-Capped Fibroatheromas: The Missing Link Toward Percutaneous Treatment: What If Diogenes Would Have Found What He Was Looking For?
J. Am. Coll. Cardiol., September 4, 2007; 50(10): 950 - 952.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.04.082v1
50/10/933    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubo, T.
Right arrow Articles by Akasaka, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kubo, T.
Right arrow Articles by Akasaka, T.
Related Collections
Right arrowRelated Article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement